entertainment -WSS

entertainment

author：knowledge 2025-09-28 12:10:19 - browse：3247

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Activists slam private health insurers over coverage restrictions

WSS

Hilary expected to bring catastrophic, life

How one medical school became remarkably diverse

Medicare proposal to cover medical devices draws a mixed reaction

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Clinical trials must include more disabled people

ProMED sees offers of support, but its future remains unclear

focus

entertainment

entertainment

23andMe had bad news about my health. I wish a person had delivered it

Walensky prepares to leave CDC — and Congress — behind

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The pain doctors face in trying to build their families

Wildfire smoke exposes gaps in outdoor worker protections

DIEP, the 'gold standard' of breast reconstruction, is under threat

Peter Hotez and the public health issue of online harassment

Beware the threat of staffing cuts at the CDC

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New details revealed about Purdue's marketing of OxyContin

knowledge

New definition of a human embryo proposed amid rapid advances

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Majority of Americans think Trump's Ga. election interference case is serious: POLL

New details revealed about Purdue's marketing of OxyContin

entertainment

knowledge

hotspot

focus